Page last updated: 2024-11-07

solutol hs 15

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Solutol HS 15: multidrug resistance modification agent in tumor cells; polyoxyethylene esters of 12-hydroxystearic acid; previous RN 105109-85-1 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124898
CHEBI ID177412
CHEBI ID9194
SCHEMBL ID505106
MeSH IDM0183826

Synonyms (17)

Synonym
2-hydroxyethyl 12-hydroxyoctadecanoate
CHEBI:177412
nsc-7395
6284-41-9
nsc7395
solutol hs 15
61909-81-7
105109-85-1
SCHEMBL505106
CHEBI:9194
2-hydroxyethyl-12-hydroxyoctadecanoate
BCP34187
DTXSID90909336
F88057
alpha-(12-hydroxy-1-oxooctadecyl)-omega-hydroxy-poly(oxy-1,2-ethanediyl)
SY236202
AKOS040744367

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Moreover, LNCs were not more toxic than their components in simple mixtures."( Cytotoxicity and genotoxicity of lipid nanocapsules.
Benoit, JP; Lagarce, F; Le Roux, G; Moche, H; Nesslany, F; Nieto, A, 2017
)
0.46

Pharmacokinetics

ExcerptReferenceRelevance
" Therefore, our results indicate that the most likely reasons for the changed pharmacokinetic behaviour of colchicine in the presence of Solutol HS 15 are alterations of metabolism and/or transport as well as distribution and elimination processes."( Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats.
Bittner, B; González, RC; Huwyler, J; Kapps, M; Walter, I, 2003
)
0.92
"The pharmacokinetic profile of midazolam (MDZ) and its major metabolites 1'-OH-midazolam (1'OH-MDZ) and 4-OH-midazolam (4OH-MDZ) was investigated in rats."( Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats.
Bittner, B; Flament, C; González, RC; Isel, H, 2003
)
0.72
" Pharmacokinetic study of the solid dispersion formulation in rat showed that bioavailability of the drug was significantly improved as compared to pure curcumin."( Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier.
Choi, HK; Chun, MK; Han, HK; Seo, SW, 2012
)
0.38
" The pharmacokinetic profile for the microemulsion showed rapid distribution and elimination compared to Diprivan(®)."( A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
Cai, W; Chen, X; Deng, W; Jin, F; Yang, H, 2012
)
0.38
" Elimination half-life was significantly lower in the SEDDM Tac group."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39
" Pharmacokinetic study demonstrated erratic brain profiles of risperidone following intraperitoneal administration in selected nanoemulsions, most probably due to their different droplet surface properties (different composition of the stabilizing layer)."( Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Cekić, ND; Daniels, R; Isailović, TM; Marković, BD; Ranđelović, DV; Savić, MM; Savić, SD; Savić, SR; Timić Stamenić, T; Đorđević, SM, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
" The results indicate that the ternary system of ME combination with HP-β-CD may be a promising approach for skin targeting delivery of KET."( Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che, J; Guo, P; Lin, Y; Pan, W; Shao, W; Wu, C; Wu, Z; Xu, Y; Zeng, W; Zhang, G, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" On the other hand, the liberation and thereby the bioavailability of poorly-soluble ethacrynic acid needs to be enhanced, and for this purpose solubility-increasing additives new to rectal therapy were used."( Solutol and cremophor products as new additives in suppository formulation.
Berkó, S; Erös, I; Regdon, G, 2002
)
0.31
"Oral bioavailability of the highly lipophilic and poorly water-soluble immunosuppressive agent cyclosporin A (CyA) in two different formulations was investigated in male Wistar rats."( Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.
Bittner, B; Bravo González, RC; Huwyler, J; Mountfield, R; Walter, I, 2002
)
0.54
" The pellets are capable of transfering lipophilic compounds into the aqueous phase and have a high potential to increase the bioavailability of lipophilic drugs."( Preparation and characterization of a self-emulsifying pellet formulation.
Abdalla, A; Mäder, K, 2007
)
0.34
"Lipid nanocapsules (LNC) are colloidal carriers providing controlled release profiles and improved bioavailability for many drug substances and diverse administration routes."( Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb, MM; Lamprecht, A; Neumann, D, 2011
)
0.37
"Dipyridamole shows poor and variable bioavailability after oral administration due to pHdependent solubility, low biomembrane permeability as well as being a substrate of P-glycoprotein."( Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: preparation and evaluation.
Guo, F; He, J; Liu, F; Liu, M; Xie, B; Xu, C; Xu, H; Zhong, H, 2011
)
0.37
" Pharmacokinetic study of the solid dispersion formulation in rat showed that bioavailability of the drug was significantly improved as compared to pure curcumin."( Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier.
Choi, HK; Chun, MK; Han, HK; Seo, SW, 2012
)
0.38
" When administering hGH nasally in rats with increasing concentrations of Solutol HS15, it was found that for a 10%w/v solution formulation a bioavailability of 49% was obtained in the first 2h after administration."( CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15.
Illum, L; Jordan, F; Lewis, AL, 2012
)
0.38
" Solid dispersion (SD) formulation was prepared with Solutol® HS15 to improve the solubility and bioavailability of curcumin."( Enhanced systemic exposure of saquinavir via the concomitant use of curcumin-loaded solid dispersion in rats.
Choi, HK; Han, HK; Kim, SA; Kim, SW, 2013
)
0.39
" The results showed that the developed SNEDDS increased the E804 bioavailability 984."( Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
Cheng, X; Eisenbrand, G; Fricker, G; Heshmati, N, 2013
)
0.39
"CriticalSorb™, with the principal component Solutol® HS15, is a novel mucosal drug delivery system demonstrated to improve the bioavailability of selected biotherapeutics."( Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures.
Illum, L; Jordan, F; Rauch, C; Shubber, S; Stolnik, S; Vllasaliu, D, 2015
)
0.42
" However, the oral bioavailability of this compound is very low due to the high pre-systemic metabolism in the colon and liver and its low water solubility."( Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies.
Bidone, J; de Lima, VR; Dora, CL; Hädrich, G; Monteiro, SO; Muccillo-Baisch, AL; Putaux, JL; Rodrigues, MR; Teixeira, HF, 2016
)
0.43
" The aim of this work was to use Solutol®HS15 and Pluronic F127 as surfactants to develop novel mixed micelles to enhance the oral bioavailability of IS by improving permeability and inhibiting efflux."( Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
Hou, J; Jia, XB; Sun, E; Wang, J; Yan, HM; Yang, L; Zhang, ZH, 2016
)
0.43
"The aim of this study was to develop a novel drug delivery system using two biocompatible copolymers of Solutol(®)HS15 and Soluplus(®) to improve solubility, oral bioavailability and anticancer activity of paclitaxel (PTX)."( Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Hou, J; Jia, XB; Sun, C; Sun, E; Wang, J; Yang, L; Zhang, ZH, 2016
)
0.43
"Rebamipide (RBP) is a potent anti-ulcer and anti-oxidative agent, which is a BCS class IV drug with a low oral bioavailability of less than 10%."( Capmul MCM/Solutol HS15-Based Microemulsion for Enhanced Oral Bioavailability of Rebamipide.
Cho, HJ; Kim, DD; Kim, KT; Lee, JY; Park, JH; Yoon, IS, 2017
)
0.46
" The performed cytotoxicity, cell apoptosis and pharmacokinetic experiments showed an enhanced bioavailability of BUF after encapsulation."( In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Angelova, A; Drechsler, M; Garamus, VM; Gong, Y; Li, N; Li, Y; Liu, J; Zou, A, 2019
)
0.51
"02-fold increase in relative oral bioavailability compared with free BAI."( Enhancing the oral bioavailability of baicalein via Solutol
Ding, P; Ju, J; Liu, Y; Shen, H; Zhang, H; Zhang, L, 2019
)
0.51
" Despite having substantial therapeutic potential, it exhibits poor absorption, low oral bioavailability and limited penetration in the brain."( Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance.
Auti, ST; Kulkarni, YA; Kunde, SS; Raju, M; Wairkar, S, 2021
)
0.62
" The pharmacokinetic results illustrated that HS15-BA increased the oral bioavailability of BA."( Improved Bioavailability and Hepatoprotective Activity of Baicalein
Liu, Q; Qi, X; Shan, J; Wang, Y; Zhang, S, 2024
)
1.44
"In summary, our study confirmed that HS15-BA micelles enhanced the bioavailability of BA, and showed hepatoprotective effects through antioxidant and anti-inflammatory activities."( Improved Bioavailability and Hepatoprotective Activity of Baicalein
Liu, Q; Qi, X; Shan, J; Wang, Y; Zhang, S, 2024
)
1.44

Dosage Studied

ExcerptRelevanceReference
" On the one hand, doctors have expressed the need to formulate a rectal suppository dosage form from diuretic ethacrynic acid, which would add to the choice of treatment methods and thereby increase the possibilities of individual cure."( Solutol and cremophor products as new additives in suppository formulation.
Berkó, S; Erös, I; Regdon, G, 2002
)
0.31
"7 h) did not differ significantly in dependence on the dosing vehicle."( Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats.
Bittner, B; González, RC; Huwyler, J; Kapps, M; Walter, I, 2003
)
0.72
" The primary cochlear cells and mouse fibroblast cells treated with LNCs displayed dosage dependant toxicity."( Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Löbler, M; Perrier, T; Pyykkö, I; Saulnier, P; Schmitz, KP; Zhang, W; Zhang, Y; Zou, J, 2011
)
0.37
" The selection of the optimum SMEDDS Tac composition might have advantage as an alternative oral dosage form for Tac."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39
"O/W emulsions were emulsified with equal dosage of egg yolk lecithin and increasing dosage of co-emulsifier (oleic acid or HS15)."( The research about microscopic structure of emulsion membrane in O/W emulsion by NMR and its influence to emulsion stability.
Chen, D; Chen, G; Chen, J; Fan, K; Lu, L; Xie, Y; Yang, F; Yang, L; Zeng, M; Zhang, S; Zhuang, Z, 2016
)
0.43
"With increasing dosage of co-emulsifier, emulsions showed two stable states, under which the signal intensity of characteristic group (orient to lipophilic core) of egg yolk lecithin disappeared in NMR of emulsions, but that (orient to aqueous phase) of co-emulsifiers only had some reduction at the second stable state."( The research about microscopic structure of emulsion membrane in O/W emulsion by NMR and its influence to emulsion stability.
Chen, D; Chen, G; Chen, J; Fan, K; Lu, L; Xie, Y; Yang, F; Yang, L; Zeng, M; Zhang, S; Zhuang, Z, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aliphatic alcoholAn alcohol derived from an aliphatic compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (88)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (6.82)18.2507
2000's17 (19.32)29.6817
2010's62 (70.45)24.3611
2020's3 (3.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.56 (24.57)
Research Supply Index4.54 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index70.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.09%)5.53%
Reviews1 (1.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other90 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]